Home › Primary Dysautonomias › NCT06827951

Potential Benefits of Parent Child Interaction Therapy (PCIT)

A Mixed-Methods Approach Utilizing Self-Report Scales and Oxytocin Levels to Determine the Potential Benefits of Parent Child Interaction Therapy (PCIT)

Who can join

Ages 18 to 89 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Parents of children aged 2-7 years old who are eligible for Parent-Child Interaction Therapy (PCIT) based on behavioral concerns.
* The primary caregiver of the child and be actively involved in the child's daily care.
* Willing to attend all PCIT sessions and complete pre-, mid- and post-intervention assessments.
* Fluent in English to ensure comprehension of the intervention and assessment materials.

Exclusion Criteria:

* Parents with diagnosed severe mental health disorders (e.g., schizophrenia, bipolar disorder) that may interfere with participation in PCIT.
* Children with conditions that require interventions other than PCIT (e.g., severe developmental disabilities).
* Parents who have previously participated in PCIT are excluded to avoid confounding results.

About the study

The goal of this study is to explore possible benefits of Parent-Child Interaction Therapy (PCIT). The main goals of the study are:

* To investigate whether pre-survey measures of autonomic reactivity relate to the overall functioning of participants. * To examine the effects of PCIT To identify individual characteristics that influence the effects of PCIT.

Participants will:

* complete 5 online surveys (1x pre-PCIT, 3x during PCIT, and 1x post-PCIT) * complete the PCIT program

What is being tested

• Parent-Child Interaction Therapy (PCIT) (behavioral)

Sponsor: University of Florida · Participants: 80 · Started: Feb 14, 2025

Contact the study team

• Britney Duner, LCSW · Phone: (904) 383-1038
• Kourtney Schroeder, PsyD · Phone: (904) 383-1038

Official record on ClinicalTrials.gov — NCT06827951

Locations in the U.S.

Conditions

• Primary Dysautonomias
• Anxiety
• Depression

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.